SKAN Group AG
SIX:SKAN
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
CH |
SKAN Group AG
SIX:SKAN
|
1.8B CHF | 5.6 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
230.1B USD | 5.4 | ||
US |
Danaher Corp
NYSE:DHR
|
193.2B USD | 4.4 | ||
US |
Agilent Technologies Inc
NYSE:A
|
44.9B USD | 6.7 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
42.3B USD | 2.8 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.6T KRW | 15 | ||
CH |
Lonza Group AG
SIX:LONN
|
38.3B CHF | 5.7 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
32.2B USD | 8.5 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.6B USD | 3.2 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
25.6B USD | 8.7 | ||
US |
Waters Corp
NYSE:WAT
|
21.4B USD | 7.4 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.